Petros Pharmaceuticals (PTPI) announces its partnership with Innolitics. The collaboration is intended to integrate many of the Company’s emerging capabilities in the ongoing development of its SaaS platform designed to complement its proprietary web application. Utilizing the same knowledge management system as multiple Fortune 100 companies and having developed software for more than 70 medical devices, Innolitics is expected to be integrating many of the Company’s recently announced cloud-based components. These enhancements include AI, cybersecurity, and others to provide potential prescription treatments and pharmaceutical sponsors with a commercially viable and enterprise scaled platform.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTPI:
- Petros Pharmaceuticals strengthens partnership with big data provider
- AI Daily: Microsoft reports earnings, says Cloud, AI ‘essential inputs’
- Petros Pharmaceuticals developing SaaS Platform using AI, EHR
- Petros Pharmaceuticals trading halted, news pending
- Petros Pharmaceuticals to effect 1-for-25 reverse stock split
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue